Učitavanje...

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes

In the combined use of bronchodilators of different classes, ie, long-acting β(2)-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs), bronchodilation is obtained both directly, through LABA-mediated stimulation of β(2)-adrenergic receptors, and indirectly, through LAMA-mediated inhibiti...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Chron Obstruct Pulmon Dis
Glavni autor: Hizawa, Nobuyuki
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2015
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4468951/
https://ncbi.nlm.nih.gov/pubmed/26089659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S72858
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!